Nothing Special   »   [go: up one dir, main page]

KR960003718A - 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용 - Google Patents

말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용 Download PDF

Info

Publication number
KR960003718A
KR960003718A KR1019950022690A KR19950022690A KR960003718A KR 960003718 A KR960003718 A KR 960003718A KR 1019950022690 A KR1019950022690 A KR 1019950022690A KR 19950022690 A KR19950022690 A KR 19950022690A KR 960003718 A KR960003718 A KR 960003718A
Authority
KR
South Korea
Prior art keywords
ifenprodil
diastereomers
treatment
peripheral
neurodegenerative diseases
Prior art date
Application number
KR1019950022690A
Other languages
English (en)
Inventor
베나비드 제쉬
페르자 바디아
조르쥬 빠스칼
스까톤 베르나르
Original Assignee
에. 뚜레 레메뜨르
신떼라보 소시에떼 아노님
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에. 뚜레 레메뜨르, 신떼라보 소시에떼 아노님 filed Critical 에. 뚜레 레메뜨르
Publication of KR960003718A publication Critical patent/KR960003718A/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

말초신경병 및 중추신경계의 만성 신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용.

Description

말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
내용없음

Claims (1)

  1. 말초신경병 및 중추신경병의 치료에 유용한 의약의 제조를 위한, 유리염기 또는 약학적으로 허용되는 산부가염 형태의 이펜프로딜 및 그 부분입체이성질체의 이용.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019950022690A 1994-07-29 1995-07-28 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용 KR960003718A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9409410A FR2722989B1 (fr) 1994-07-29 1994-07-29 Utilisation de l'ifenprodil et de ses enantiomeres pour la preparation de medicaments utiles dans le traitement des neuropathies peripheriques et des maladies neurodegeneratives centrales
FR94-09410 1994-07-29

Publications (1)

Publication Number Publication Date
KR960003718A true KR960003718A (ko) 1996-02-23

Family

ID=9465882

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950022690A KR960003718A (ko) 1994-07-29 1995-07-28 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용

Country Status (8)

Country Link
US (1) US5543421A (ko)
EP (1) EP0698391A1 (ko)
JP (1) JPH0840902A (ko)
KR (1) KR960003718A (ko)
CA (1) CA2154906A1 (ko)
FI (1) FI953622A (ko)
FR (1) FR2722989B1 (ko)
NO (1) NO953003L (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742051B1 (fr) * 1995-12-06 1998-02-06 Synthelabo Utilisation de composes ayant une affinite pour le site de liaison du (3h)ifenprodil pour la fabrication de medicaments utiles dans la prevention et le traitement des neuropathies
GB0210264D0 (en) * 2002-05-03 2002-06-12 Arakis Ltd The treatment of pain and migraine headache
UA113165C2 (xx) * 2011-03-01 2016-12-26 Застосування комбінації баклофену і акампросату для лікування неврологічних захворювань та композиція, яка містить баклофен і акампросат
WO2016049700A1 (en) 2014-10-03 2016-04-07 Lachesis Biosciences Pty Ltd Intranasal compositions for treatment of neurological and neurodegenerative diseases and disorders
JPWO2021241504A1 (ko) * 2020-05-25 2021-12-02

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5733M (ko) * 1966-09-27 1968-01-22
US5089506A (en) * 1990-04-30 1992-02-18 G. D. Searle & Co. Ethanobicyclic amine derivatives for cns disorders
WO1992003137A1 (en) * 1990-08-23 1992-03-05 The Children's Medical Center Corporation Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss
GB9026389D0 (en) * 1990-12-05 1991-01-23 Merck Sharp & Dohme Therapeutic agents
US5118675A (en) * 1991-02-15 1992-06-02 American Home Products Corporation Quinoxaline phosphono-amino acids
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
FR2678269B1 (fr) * 1991-06-27 1995-01-13 Synthelabo Derives de 1-(4-chlorophenyl)-2-[4-(2-phenylethyl)piperidin-1-yl]ethanol, leur application et leur preparation en therapeutique.

Also Published As

Publication number Publication date
US5543421A (en) 1996-08-06
CA2154906A1 (en) 1996-01-30
FR2722989A1 (fr) 1996-02-02
FI953622A (fi) 1996-01-30
JPH0840902A (ja) 1996-02-13
EP0698391A1 (fr) 1996-02-28
FR2722989B1 (fr) 1997-05-30
FI953622A0 (fi) 1995-07-28
NO953003L (no) 1996-01-30
NO953003D0 (no) 1995-07-28

Similar Documents

Publication Publication Date Title
KR900701261A (ko) 비만증 치료방법
KR920019342A (ko) 골질환 치료제
KR960700742A (ko) 아토피성질환 치료약(atopic disease remedy)
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
CA2122612A1 (en) Pharmaceutical products for curing tumourous diseases and process for preparing same
ATE211907T1 (de) Osmotisches arzneimittelfreisetzungssystem
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
PT913156E (pt) Utilizacao de proteina c activada para tratar estados hipercoagulaveis associados com sepsia
ES2171469T3 (es) Composicion administrada por via nasal y preparacion que la contiene.
ES2173111T3 (es) Uso de fenserina para la preparacion de medicamentos para el tratamiento de desordenes cognoscitivos.
KR890015742A (ko) 이병치료용 국소 제제
CA2433833A1 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence
KR940018087A (ko) 진통제 및 소염제로서의 6-클로로-5-플루오로-3-(2-테노일)-2-옥신돌-ⅰ-카복스아미드
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
KR930019224A (ko) 유산 위험 치료제
KR890003373A (ko) 수면장애 및 우울증 치료에 화합물의 이용
KR890007728A (ko) 진통제 제조방법
RU94032792A (ru) Применение 5нтiа - антагонистов для прекращения использования табака
KR960003717A (ko) 항암제에 의해 유발되는 말초신경병의 예방에 유용한 의약의 제조를 위한 엘리프로딜 및 그 거울상이성질체의 이용
IT1224250B (it) Associzione del depiprazolo con la morfina
BR9801839A (pt) Medicamento analgésico e aplicação de (+) -0-demetiltramadol.
KR900017599A (ko) 종양 치료용 약학 조성물
FR2818147B1 (fr) Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine
KR950007852A (ko) 우라실을 유효성분으로 함유하는 관절염 치료제

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid